Skip to main content

Liver lectins: mediators for metastases?

Summary

Development of liver metastases in 1542 cancer patients was investigated. It was found that in certain liver diseases the incidence of liver metastases was reduced compared to that in cancer patients with otherwise normal livers. We propose that this reduction may be due to a reduced function of the liver-specific lectins.

This is a preview of subscription content, access via your institution.

References

  1. Marshall, J.S., Green, A.M., Pensky, Z., Williams, S., Zinn, A., and Carlson, D.M., J. clin. Invest.54 (1974) 555.

    PubMed  Google Scholar 

  2. Ashwell, G., and Harford, J., A. Rev. Biochem.51 (1982) 531.

    Google Scholar 

  3. Newman, R.A., Fricke, U., Klein, P.J., Uhlenbruck, G., and DeVries, A.L., J. clin. Chem. clin. Biochem.18 (1980) 31.

    PubMed  Google Scholar 

  4. Springer, G.F., Desai, P.R., and Scanlon, E.F., Cancer37 (1976) 169.

    PubMed  Google Scholar 

  5. Uhlenbruck, G., and Gielen, W., Fortschr. Neurol. Psychiatr.38 (1970) 202.

    Google Scholar 

  6. Newman, R.A., Klein, P.J., Uhlenbruck, G., Citoler, P., and Karduck, D., J. Cancer Res. clin. Oncol.93 (1979) 181.

    PubMed  Google Scholar 

  7. Uhlenbruck, G., Immun. Commun.10 (1981) 251.

    Google Scholar 

  8. McFarlane, I.G., Clin. Sci.64 (1983) 127.

    PubMed  Google Scholar 

  9. Schirrmacher, V., Cheingsong-Popov, R., and Arnheiter, H., J. exp. Med.151 (1980) 984.

    PubMed  Google Scholar 

  10. Schirrmacher, V., personal communication.

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Uhlenbruck, G., Beuth, J. & Weidtman, V. Liver lectins: mediators for metastases?. Experientia 39, 1314–1315 (1983). https://doi.org/10.1007/BF01990389

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01990389

Keywords

  • Cancer Patient
  • Liver Disease
  • Liver Metastasis
  • Normal Liver
  • Liver Lectin